Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Lansoprazole Usage on Bone Turnover Markers in Children With Gastroesophageal Reflux or Gastroesophageal Reflux Disease

NCT04814316 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT04814316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04814316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Lansoprazole Usage on Bone Turnover Markers in Children With Gastroesophageal Reflux or Gastroesophageal Reflux Disease
Lead sponsor
Ataturk University
Phase
Observational
Overall status
Completed
Start date
December 2, 2019
Completion date
July 1, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone turnover rate disorder, calcium metabolism disorders